Biotechnology Today
more-
Stanford’s new 5-hour DNA sequencing technique lands Guinness World Record
Though much of the current innovation in the healthcare field is aimed at speeding up…
PacBio lets Google peek under the hood to help boost its long-read DNA sequencing accuracy
Renalytix plots de novo FDA nod for kidney disease AI, expands into drug response monitoring
Fending off heart disease by blocking how immune cells ‘smell’ their surroundings
Philips, still hobbled by expanded ventilator recall, braces for Q4 earnings miss
Markets
more-
Weekly Market Review – January 15, 2022
Stock Markets As the official start of the earnings season begins, the large-cap indexes posted…
Bio Space
more
EMA sets out plan to accelerate clinical trials, reduce administrative burden
The European Medicines Agency (EMA) wants to speed up your…
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
Mithra has brushed off a missed co-primary endpoint in one…
Galapagos execs troll for deals at J.P. Morgan but will hold off on signing for CEO-in-waiting
After dropping a late-stage asset and hitting an FDA roadblock…
Global News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Stanford’s new 5-hour DNA sequencing technique lands Guinness World Record
PacBio lets Google peek under the hood to help boost its long-read DNA sequencing accuracy
Renalytix plots de novo FDA nod for kidney disease AI, expands into drug response monitoring
Fending off heart disease by blocking how immune cells ‘smell’ their surroundings
EMA sets out plan to accelerate clinical trials, reduce administrative burden
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
Galapagos execs troll for deals at J.P. Morgan but will hold off on signing for CEO-in-waiting
Fosun Pharma invests in Insilico Medicine for its AI drug discovery programs
Philips, still hobbled by expanded ventilator recall, braces for Q4 earnings miss
Editas, which caught flak in 2021 for limited gene editing data, will try to layer on the proof in 2022